Clinical Trials Logo

Lymphedema clinical trials

View clinical trials related to Lymphedema.

Filter by:
  • Enrolling by invitation  
  • « Prev · Page 2

NCT ID: NCT02550951 Enrolling by invitation - Lymphedema Clinical Trials

Utility of MR Lymphangiography in Postoperative Follow-up of Lymphedema: Comparison With Lymphoscintigraphy

Start date: October 2014
Phase: N/A
Study type: Interventional

Its usefulness in implementing magnetic resonance angiography for postoperative follow-up of lymph lymphedema should try to evaluate and compare lymphoscintigraphy.

NCT ID: NCT02375165 Enrolling by invitation - Lymphedema Clinical Trials

Biomarkers for the Detection of Lymphatic Insufficiency

Biomarkers
Start date: September 2009
Phase:
Study type: Observational

Acquired lymphedema is a disease that causes chronic swelling of the limb(s). It is frequently under-recognized or misdiagnosed. This study is designed to lead to the development of an accurate, noninvasive, blood test to allow testing for lymphedema. This approach is particularly useful to investigate relative responses to treatment interventions.

NCT ID: NCT01273909 Enrolling by invitation - Breast Cancer Clinical Trials

Outcomes After Perforator Flap Reconstruction for Breast Reconstruction and/or Lymphedema Treatment

Start date: July 2010
Phase: N/A
Study type: Observational

The goal of this prospective, observational study is to investigate the clinical, psychosocial, and patient satisfaction outcomes of patients who undergo perforator flap reconstruction for breast reconstruction and/or vascularized lymph node transfer (VLNTx) for the treatment of lymphedema. The investigators hypothesize that (1) perforator flap breast reconstruction will result in excellent clinical, psychosocial, and patient satisfaction outcomes compared to non-perforator flap breast reconstruction; (2) perforator flap breast reconstruction is associated with less persistent postsurgical pain than other forms of breast reconstruction, even after controlling for major cofactors, such as the extent of auxiliary lymph node dissection and the use of radiation therapy; (3) perforator flap reconstruction for the treatment of Lymphedema (i.e., VLNTx ) will result in the reduction of symptoms and complications of lymphedema.

NCT ID: NCT00833599 Enrolling by invitation - Lymphedema Clinical Trials

Imaging Lymphatic Function in Normal Subjects and in Persons With Lymphatic Disorders

Start date: January 2009
Phase:
Study type: Observational

The purpose of this study is to demonstrate the feasibility of near-infrared fluorescence imaging in subjects with acquired or hereditary lymphedema, in subjects with lipidema and other lymphovascular disorders and in normal health subjects; in order to attempt to correlate imaging phenotype(s) with genotype(s).